Dr. Shumei Kato
Claim this profileUC San Diego Moores Cancer Center
Studies Solid Tumors
Studies Colorectal Cancer
14 reported clinical trials
43 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
EGFR positive
2Colorectal Cancer
Stage IV
KRAS negative
NRAS negative
Affiliated Hospitals
Clinical Trials Shumei Kato is currently running
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria
Temozolomide + Tuvusertib
for Cancer
This trial tests a combination of two drugs, temozolomide and M1774, in patients with advanced cancer that has spread. Temozolomide damages cancer cell DNA, while M1774 blocks growth enzymes. The goal is to find a more effective treatment for these patients.
Recruiting1 award Phase 1 & 2
More about Shumei Kato
Clinical Trial Related8 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Shumei Kato has experience with
- Ulixertinib
- Trifluridine And Tipiracil Hydrochloride
- BI 754091
- BI 836880
- BI 754111
- MCLA-158
Breakdown of trials Shumei Kato has run
Colorectal Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shumei Kato specialize in?
Shumei Kato focuses on Solid Tumors and Colorectal Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Shumei Kato currently recruiting for clinical trials?
Yes, Shumei Kato is currently recruiting for 5 clinical trials in La Jolla California. If you're interested in participating, you should apply.
Are there any treatments that Shumei Kato has studied deeply?
Yes, Shumei Kato has studied treatments such as Ulixertinib, Trifluridine and Tipiracil Hydrochloride, BI 754091.
What is the best way to schedule an appointment with Shumei Kato?
Apply for one of the trials that Shumei Kato is conducting.
What is the office address of Shumei Kato?
The office of Shumei Kato is located at: UC San Diego Moores Cancer Center, La Jolla, California 92093 United States. This is the address for their practice at the UC San Diego Moores Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.